Esophageal Cancer Survival Extended
Immunotherapy Extends Survival in Esophageal Cancer December 02, 2020 The immunotherapy drug pembrolizumab, known by its brand name Keytruda, is a safe and effective option for patients with locally advanced and metastatic squamous cell...
Read more